Satsuma Pharmaceuticals Free Cash Flow 2020-2023 | STSA
Satsuma Pharmaceuticals free cash flow from 2020 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Satsuma Pharmaceuticals Annual Free Cash Flow |
| 2022 |
-51.99 |
| 2021 |
-45.03 |
| 2020 |
-47.49 |
| 2019 |
-30.19 |
| 2018 |
-7.38 |
| 2017 |
-4.38 |
| Satsuma Pharmaceuticals Quarterly Free Cash Flow |
| 2023-03-31 |
-11.39 |
| 2022-12-31 |
-51.99 |
| 2022-09-30 |
-39.76 |
| 2022-06-30 |
-26.34 |
| 2022-03-31 |
-14.34 |
| 2021-12-31 |
-45.03 |
| 2021-09-30 |
-31.40 |
| 2021-06-30 |
-21.09 |
| 2021-03-31 |
-9.76 |
| 2020-12-31 |
-47.49 |
| 2020-09-30 |
-34.47 |
| 2020-06-30 |
-23.50 |
| 2020-03-31 |
-13.30 |
| 2019-12-31 |
-30.19 |
| 2019-09-30 |
-22.91 |
| 2019-06-30 |
-11.62 |
| 2019-03-31 |
-3.08 |
